Latest news with #3DSystems
Malaysian Reserve
7 days ago
- Business
- Malaysian Reserve
DDD Investors Have the Opportunity to Lead the 3D Systems Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In 3D Systems To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in 3D System between August 13, 2024 and May 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, July 8, 2025 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against 3D Systems Corporation ('3D Systems' or the 'Company') (NYSE: DDD) and reminds investors of the August 12, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) 3D Systems had understated the impact of weakened customer spending on the Company's business, while overstating its resilience in challenging industry conditions; (2) in addition, the updated milestone criteria in the United Partnership would negatively impact the Company's Regenerative Medicine Program revenue; and (3) as a result, the Company's public statements were materially false and misleading at all relevant times. On March 26, 2025, 3D Systems issued a press release announcing its financial results for the fourth quarter ('Q4') and full-year 2024. Among other items, 3D Systems reported Q4 non-GAAP earnings-per-share of –$0.19, missing consensus estimates by $0.08 per share, and sales revenue of $111 million, representing a -3.4% year-over-year decline and missing consensus estimates by $4.17 million. Further, for full-year 2024, the Company reported sales of $440.1 million, a decrease of 10% compared to the prior year, driven by 'lower hardware systems sales due to macroeconomic factors that are negatively impacting demand.' Finally, 3D systems reported a '$9 million revenue reduction in Q4 driven by a change in accounting estimates for [the Company's] Regenerative Medicine program.' The Company disclosed that '[t]his change in estimate [was] related to the now anticipated use of pre-clinical human decedent testing[,] [. . .] which led to refinement of the milestone technical criteria.' On this news, 3D Systems' stock price fell $0.57 per share, or 20.96%, to close at $2.15 per share on March 27, 2025. Then, after the market closed on May 12, 2025, 3D Systems issued a press release announcing its financial results for the first quarter ('Q1') of 2025. Among other items, 3D systems reported: revenue of $94.5 million, down 8% year-over-year and missing consensus estimates of $99.5 million; a net loss of $37 million, or $0.28 per share, more than doubling the $16 million loss reported in Q1 2024; an adjusted loss of $0.21 per share, deeper than consensus estimates of a loss of $0.14 per share; and adjusted EBITDA of a loss of $23.9 million, deepening from a $20.1 million loss in Q1 2024. The Company attributed its disappointing results, in part, to a decline in material sales, mostly due to inventory management issues in the dental portion of its Healthcare Solutions segment. 3D Systems also announced that it was withdrawing its full-year 2025 outlook, citing prolonged softness in customer capital spending and macroeconomic uncertainty. On this news, 3D Systems' stock price fell $0.68 per share, or 26.6%, to close at $1.87 per share on May 13, 2025. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding 3D Systems' conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the 3D Systems class action, go to or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Follow us for updates on LinkedIn, on X, or on Facebook. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.
Malaysian Reserve
07-07-2025
- Business
- Malaysian Reserve
Shareholders who own 3D Systems (NYSE: DDD) Should Contact Wolf Haldenstein
NEW YORK, July 7, 2025 /PRNewswire/ — Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that securities class action lawsuit has been filed in the United States District Court for the District of Delaware on behalf of all persons or entities who purchased or otherwise acquired 3D Systems Corporation (3D Systems or the Company) (NYSE: DDD) securities between August 13, 2024 and May 12, 2025, inclusive (the Class Period). Investors who purchased or otherwise acquired shares of 3D Systems should contact the Firm prior to the August 12, 2025 lead plaintiff motion deadline. PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION The lawsuit alleges that during the Class Period, 3D Systems and certain of its executives made materially false and/or misleading statements and failed to disclose critical information, including: The Company understated the impact of weakened customer spending and overstated its resilience amid challenging industry conditions. Revised milestone criteria in the United Partnership would adversely affect revenues from the Company's Regenerative Medicine Program. As a result, the Company's public statements were materially misleading. On March 26, 2025, 3D Systems reported disappointing financial results for Q4 and full-year 2024, including: Q4 2024 non-GAAP EPS of – $0.19, missing consensus by $0.08 per share; Sales revenue of $111 million, down 3.4% year-over-year, missing estimates by $4.17 million; Full-year 2024 revenue of $440.1 million, a 10% decline from the prior year, largely due to weaker hardware system sales; A $9 million Q4 revenue reduction related to changes in accounting estimates tied to its Regenerative Medicine Program and milestone refinements. Following this news, shares of 3D Systems fell 20.96%, closing at $2.15 per share on March 27, 2025. Subsequently, on May 12, 2025, 3D Systems issued a press release announcing its financial results for the first quarter ('Q1') of Company attributed its disappointing results, in part, to a decline in material sales, mostly due to inventory management issues in the dental portion of its Healthcare Solutions segment. 3D Systems also announced that it was withdrawing its full-year 2025 outlook, citing prolonged softness in customer capital spending and macroeconomic uncertainty. On this news, 3D Systems' stock price fell $0.68 per share, or 26.6%, to close at $1.87 per share on May 13, 2025. PLEASE CLICK HERE TO JOIN THE CASE AND SUBMIT CONTACT INFORMATION Why Wolf Haldenstein Adler Freeman & Herz LLP?: This illustrious firm, founded in 1888, is steadfast in their pursuit of justice for investors who have suffered financial harm due to these misrepresented statements. The law firm brings to the fore over 125 years of legal expertise in securities litigation and has a proven track record of protecting the rights of investors. We encourage all investors who have been affected or have information that will assist in our investigation, to contact Wolf Haldenstein Adler Freeman & Herz LLP. Contact: Phone: (800) 575-0735 or (212) 545-4774 Email: classmember@ Contact Person: Gregory Stone, Director of Case and Financial Analysis Firm Website: Wolf Haldenstein Adler Freeman & Herz LLP This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Associated Press
06-07-2025
- Business
- Associated Press
SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of 3D Systems
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In 3D Systems To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $50,000 in 3D System between August 13, 2024 and May 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] NEW YORK, July 06, 2025 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against 3D Systems Corporation ('3D Systems' or the 'Company') (NYSE: DDD) and reminds investors of the August 12, 2025 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The firm has recovered hundreds of millions of dollars for investors since its founding in 1995. See As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) 3D Systems had understated the impact of weakened customer spending on the Company's business, while overstating its resilience in challenging industry conditions; (2) in addition, the updated milestone criteria in the United Partnership would negatively impact the Company's Regenerative Medicine Program revenue; and (3) as a result, the Company's public statements were materially false and misleading at all relevant times. On March 26, 2025, 3D Systems issued a press release announcing its financial results for the fourth quarter ('Q4") and full-year 2024. Among other items, 3D Systems reported Q4 non-GAAP earnings-per-share of -$0.19, missing consensus estimates by $0.08 per share, and sales revenue of $111 million, representing a -3.4% year-over-year decline and missing consensus estimates by $4.17 million. Further, for full-year 2024, the Company reported sales of $440.1 million, a decrease of 10% compared to the prior year, driven by 'lower hardware systems sales due to macroeconomic factors that are negatively impacting demand.' Finally, 3D systems reported a "$9 million revenue reduction in Q4 driven by a change in accounting estimates for [the Company's] Regenerative Medicine program.' The Company disclosed that "[t]his change in estimate [was] related to the now anticipated use of pre-clinical human decedent testing[,] [. . .] which led to refinement of the milestone technical criteria.' On this news, 3D Systems' stock price fell $0.57 per share, or 20.96%, to close at $2.15 per share on March 27, 2025. Then, after the market closed on May 12, 2025, 3D Systems issued a press release announcing its financial results for the first quarter ('Q1") of 2025. Among other items, 3D systems reported: revenue of $94.5 million, down 8% year-over-year and missing consensus estimates of $99.5 million; a net loss of $37 million, or $0.28 per share, more than doubling the $16 million loss reported in Q1 2024; an adjusted loss of $0.21 per share, deeper than consensus estimates of a loss of $0.14 per share; and adjusted EBITDA of a loss of $23.9 million, deepening from a $20.1 million loss in Q1 2024. The Company attributed its disappointing results, in part, to a decline in material sales, mostly due to inventory management issues in the dental portion of its Healthcare Solutions segment. 3D Systems also announced that it was withdrawing its full-year 2025 outlook, citing prolonged softness in customer capital spending and macroeconomic uncertainty. On this news, 3D Systems' stock price fell $0.68 per share, or 26.6%, to close at $1.87 per share on May 13, 2025. The court-appointed lead plaintiff is the investor with the largest financial interest in the relief sought by the class who is adequate and typical of class members who directs and oversees the litigation on behalf of the putative class. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member. Your ability to share in any recovery is not affected by the decision to serve as a lead plaintiff or not. Faruqi & Faruqi, LLP also encourages anyone with information regarding 3D Systems' conduct to contact the firm, including whistleblowers, former employees, shareholders and others. To learn more about the 3D Systems class action, go to or call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). Follow us for updates on LinkedIn, on X, or on Facebook. Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP ( ). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner. A photo accompanying this announcement is available at
Associated Press
05-07-2025
- Business
- Associated Press
ROSEN, A LONGSTANDING FIRM, Encourages 3D Systems Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action
New York, New York--(Newsfile Corp. - July 5, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of 3D Systems Corporation (NYSE: DDD) between August 13, 2024 and May 12, 2025, both dates inclusive (the 'Class Period'), of the important August 12, 2025 lead plaintiff deadline. SO WHAT: If you purchased 3D Systems securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the 3D Systems Corporation class action, go to or call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than August 12, 2025. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. WHY ROSEN LAW: We encourage investors to select qualified counsel with a track record of success in leadership roles. Often, firms issuing notices do not have comparable experience, resources, or any meaningful peer recognition. Many of these firms do not actually litigate securities class actions, but are merely middlemen that refer clients or partner with law firms that actually litigate the cases. Be wise in selecting counsel. The Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation. Rosen Law Firm achieved the largest ever securities class action settlement against a Chinese Company at the time. Rosen Law Firm was Ranked No. 1 by ISS Securities Class Action Services for number of securities class action settlements in 2017. The firm has been ranked in the top 4 each year since 2013 and has recovered hundreds of millions of dollars for investors. In 2019 alone the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs' Bar. Many of the firm's attorneys have been recognized by Lawdragon and Super Lawyers. DETAILS OF THE CASE: According to the lawsuit, during the Class Period, defendants made false and/or misleading statements and/or failed to disclose that: (1) 3D Systems had understated the impact of weakened customer spending on 3D Systems' business, while overstating its resilience in challenging industry conditions; (2) in addition, the updated milestone criteria in the United Partnership (a partnership with United Therapeutics Corporation) would negatively impact 3D Systems' Regenerative Medicine Program revenue; and (3) as a result, 3D Systems' public statements were materially false and misleading at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages. To join the 3D Systems class action, go to call Phillip Kim, Esq. toll-free at 866-767-3653 or email [email protected] for information on the class action. No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor's ability to share in any potential future recovery is not dependent upon serving as lead plaintiff. Follow us for updates on LinkedIn: or on Twitter: or on Facebook: Attorney Advertising. Prior results do not guarantee a similar outcome. ------------------------------- Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 40th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] To view the source version of this press release, please visit
Globe and Mail
04-07-2025
- Business
- Globe and Mail
Technology Landscape, Trends and Opportunities in 3D Printing Photopolymer Market
Over the past decade, technologies within the 3D printing photopolymer market have evolved to become increasingly divergent, shifting from conventional stereolithography (SLA) to more advanced Digital Light Processing (DLP) and PolyJet technologies. Such changes indicate a growing demand for faster production speeds, higher resolution, and more versatile material properties in photopolymer 3D printing. Over the past decade, technologies within the 3D printing photopolymer market have evolved to become increasingly divergent, shifting from conventional stereolithography (SLA) to more advanced Digital Light Processing (DLP) and PolyJet technologies. Such changes indicate a growing demand for faster production speeds, higher resolution, and more versatile material properties in photopolymer 3D printing. Download sample by clicking on Stratasys, 3D Systems, Evonik, Formlabs, Envision TEC, DSM Somos are among the major technology providers in the 3D printing photopolymer market. Lucintel, a leading global management consulting and market research firm with over 1,000 clients worldwide, has analyzed the technologies used in 3D printing photopolymer market and has now published a comprehensive research report titled "Technology Landscape, Trends and Opportunities in the Global 3D Printing Photopolymer Market 2024-2030". This report analyzes technology maturity, degree of disruption, competitive intensity, market potential, and other parameters of various technologies in the 3D printing photopolymer technology market. The study includes trends and forecast for the technology trends in the 3D printing photopolymer market various segmentations as below: 3D Printing Photopolymer Market Trend and Forecast by Technology [Value from 2019 to 2031]: • Digital Light Processing • Polyjet • Stereolithography (SLA) 3D Printing Photopolymer Market Trend and Forecast by End Use Industry [Value from 2019 to 2031]: • Aerospace & Defense • Healthcare • Automotive 3D Printing Photopolymer Market by Region [Value from 2019 to 2031]: • North America • Europe • Asia Pacific • The Rest of the World Latest Developments and Innovations in the 3D Printing Photopolymer Technologies Companies / Ecosystems Strategic Opportunities by Technology Type A more than 150-pages research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link helpdesk@ About Lucintel Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit Explore Our Latest Publications Technology Landscape, Trends and Opportunities in Aircraft Fuel System Market Technology Landscape, Trends and Opportunities in Diode Pump Solid State Lasers Market Technology Landscape, Trends and Opportunities in E-Commerce Fraud Detection Solutions Market Technology Landscape, Trends and Opportunities in Exhaust Heat Recovery System Market Technology Landscape, Trends and Opportunities in Molten Carbonate Fuel Cell Market Media Contact Company Name: Lucintel Contact Person: Roy Almaguer Email: Send Email Phone: 972.636.5056 Address: 8951 Cypress Waters Blvd., Suite 160 City: Dallas State: TEXAS Country: United States Website:
